> Imprima

Bronchioloalveolar Carcinoma of Lung

This article has been archived.
Please use for reference only.

Li Liu, MD
The Abramson Cancer Center of the University of Pennsylvania
Ultima Vez Modificado: 1 de noviembre del 2001

Question
Dear OncoLink "Ask the Experts,"
One of my family members has bronchioloalveolar carcinoma of lung with distant metastases. She is going to have a surgery to remove a tumor from her leg. She would like to know what NEW treatment she can take after the surgery? What chemotherapy & radiation trials can she participate in?


Answer
Li Liu, MD, OncoLink editorial assistant, responds:

Thank you for your interest and question.

There are a few National Cancer Institute (NCI) sponsored trials available for Stage IV non-small cell lung cancer.

  • Phase II study of Dolsatatin 10 in patients with advanced non-small cell lung cancer. MSKCC-98070, NCI-T98-0016.
  • Phase II study of a 96-hour continuous infusion of Paclitaxel followed by Cisplatin for advanced or Relapsed non-small cell lung cancer. NCI-95-C-0198.
  • Phase II study of Paclitaxel (Taxol) by 96 hour infusion in patients with Stage IIIB or Stage IV bronchioloalveolar carcinoma. SWOG-9714.
  • Phase II randomized study of Carboplatin and Gemcitabine (Gemzar®) followed by Paclitaxel vs Cisplatin and Vinorelbine followed by Docetaxel in patients with advanced non-small cell lung cancer. SWOG-9806.
More trials can be found at the NCI Web site. The majority of the trials require measurable or evaluable disease. You should talk to your physician regarding these trials.

Blogs

I wish u knew... about life after cancer
by Timothy J. Hampshire
October 08, 2012

Related News

Genomic Alterations ID'd in Lung Squamous Cell Carcinoma

Sep 12, 2012

Hundreds of mutations found per tumor; statistically recurrent mutations in TP53


High VEGF Signaling Score Tied to Lung Cancer Prognosis

Feb 23, 2012

High score correlates with good prognosis in patients with early lung squamous cell carcinoma


ALA: Women Have Misperceptions About Lung Cancer

May 15, 2014

Report shows many women are unaware of incidence, poor survival rates, risk for nonsmokers